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WEB 2.0 COMO FERRAMENTA PARA GESTÃO DE REDES E ANÁLISE DE 
PATENTES EM SAÚDE PÚBLICA 
 
 
 
RESUMO 
 
A intensidade em que ocorrem as pesquisas para novas drogas e medicamentos contribui 
significantemente para a inovação e o desenvolvimento tecnológico da Saúde de uma nação. Nesse 
sentido, este trabalho objetiva demonstrar como algumas ferramentas de acesso livre da Web 2.0 
podem auxiliar os países em desenvolvimento, bem como os não desenvolvidos, na gestão de redes 
e análise de patentes para apoio na atenção à saúde, especificamente, tendo como exemplo a 
tuberculose. As correlações de vários especialistas no mundo e em diversas bases do conhecimento 
podem contribuir na geração de novas abordagens e resultados, no sentido de auxiliar melhor os 
tomadores de decisão das empresas, governos ou organizações. As publicações e os países onde 
existem redes de pesquisa em tubérculos são demonstrados em mapa global. Também é descrito um 
exemplo específico para gestão tecnológica usando patentes em tuberculose. 
 
Palavras-chave: Gestão em Saúde; Web 2.0; Patentes; Doenças Negligenciadas; Inteligência 
Competitiva. 
 
 
 
 
 
 
 
WEB 2.0 TOOLS FOR NETWORK MANAGEMENT AND PATENT ANALYSIS FOR 
HEALTH PUBLIC 
 
 
ABSTRACT 
 
Intensity in research on drugs and medicines contributes significantly to innovation and 
technological development in the country's health. Thus, this work aimed evinces how Web 2.0 
tools of free access can help developing and undeveloped nations in the network management and 
patent analysis for health care, in this case for tuberculosis. The co-relation of a lot of experts in the 
world with several knowledge bases can contribute to generation of new approaches and results as 
well as assist in better decision making by managers of companies, governments and organizations. 
Countries and publications by research networks in tuberculosis are listed in worldwide. We also 
describe a specific example for technological management using tuberculosis patents. 
 
Keywords: Health Management; Web 2.0; Patents; Neglected Disease; Competitive Intelligence. 
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1 BACKGROUND 
 
According to the Organization for Economic Co-operation and Development (OECD), 55% 
of global wealth is in the knowledge (OECD, 2008). Drucker (Drucker, 2006) points out that the 
increase in the generation of this knowledge will occur with the increase of knowledge 
management. 
New trends influence the industrial development of a country, such as the knowledge, like a 
main resource and the learning, like a central process. Therefore, it is essential to broaden the base 
of expertise in human resources and hence increasing the innovation potential (Lastres & Sarita, 
1999). 
Formation of competencies for innovation requires previously defined as an intelligence 
cooperative, which translates as construction of knowledge in collaboration with peers at work. This 
mindset requires collaborative development processes capable of producing high quality 
information for scientific and technological knowledge. The experts have unrestricted access to 
information created by the scientific community, collaborative review of the contributions of 
members, governance based more on authority than on sanctions, and involvement in integrated 
levels and responsibilities (Ambrosi, Peugeot, & Pimenta, 2005). 
In 1977, Tidd, Pavitt and Bessant discussed innovation as a change in products and services 
offered by an organization or even a change in the process or in a way to prepare the products or 
services. It also can be considered the way this organization delivers its products (Tidd, Pavitt, & 
Bessant, 2005). 
Success of the activities of companies, research groups, government and institutions of 
countries are effective when they attribute value and quality in their information considered critical. 
These factors will lead the organization to succeed in their internal and external planning such as 
strategies for short and long term. Thus, the capital of intellectual property plays an important role 
in enterprises and knowledge becomes increasingly "key" to competitiveness, technology and so 
economic development. This happens mainly in the sectors of high density technology where 
knowledge is considered like the most important asset of the company (Quoniam, 2011). 
Therefore, it is essential to invest in Research, Development and Innovation (R,D&I) so that 
an organization stay active and competitive. Information Science provides Web 2.0 tools that can 
help in the generation, treatment, storage and data management of any activities or processes, 
providing a better management system for innovation. Due to market system increasingly turbulent 
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beyond complex and competitive business in which they operate, the use of new approaches such as 
Intellectual/Industrial Property becomes the guarantee of continuity of their activities (Pierret, 
2006). 
Search engines have evolved from manual information’s for portals or websites dedicated 
(Web 1.0 to Web 2.0i) – passed for a massive amount of information in an automated model. This 
new paradigm allows the download of a huge amount of data in different formats, but they cannot 
do the same processing for the production of indicators for decision making. Hence, studies are 
needed using the tools of information science such as forecasting in technology trends (Quoniam & 
Lucien, 2010). 
Using this approach is salutary to identify and promote the synergy of these experts to 
advance science. Thus, the innovation will be achieved through technological development in 
certain areas. Linking this statement with the approach of this work is expected to contribute in the 
management area to improving the treatment, alerts and ways for diseases’ eradication (Magalhães, 
Boechat, & Antunes, 2012a). Therefore, from the democratization of knowledge provided by the 
Web 2.0 tools using open access, it is possible to demonstrate the use of indicators for non-
specialists democratized. 
One footstep can be observed in figure 1, a global health map that brings together disparate 
data sources, including online news aggregators, eyewitness reports, expert-curated discussions and 
validated official reports, to achieve a unified and comprehensive view of the current global state of 
infectious diseases and their effect on human and animal health. Each point on the map indicates, in 
accordance with the color intensity, the highest or the lowest level of a certain disease. Another 
example is analysis in information from patents that can be incorporated into the competitive 
technological strategy of companies in a great variety of ways. It serves as an indicator of future 
developments in technology and gives your own company a decisive lead in its actions. 
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Figure 1 - A Global Health Map (HealthMap | Global Health, Local Knowledge, 2013). 
 
 
Reflecting on health, the WHO Constitution enshrines as a fundamental right to health of 
every human being access to timely, acceptable, and affordable health care of appropriate quality 
(“WHO | The right to health”, 2012). Accordingly, the global pharmaceutical industry contributes 
providing medicines through research them. In 2012, medicines sales surpassed US$ 900 billion 
with trend to reach US$ 1,2 trillion by 2016 (IMS Institute for Healthcare Informatics, 2012) 
(Magalhães, Quoniam, & Boechat, 2013). However, this volume does not meet properly marketed 
to most of the world population (WHO, 2008), of which 80% live in middle or low income 
countries. Corroborates this fact when there is a lack of medicines for neglected diseases (ND), 
considering that mainly affect populations with low purchasing power and therefore do not provide 
sufficient incentive for pharmaceutical industry to invest in Research and Development (R&D). 
WHO estimates that there are about 1 billion people suffering some ND. However, the challenge is 
best understood when we think of neglected populations, i.e., include not only new treatments for 
ND, but also access to antimicrobials, affordable medicines for diseases with global impact as 
diabetes and cancer (Moon, Bermudez, & ’t Hoen, 2012). 
Among these diseases forgotten by the pharmaceutical industry, exemplify the tuberculosis 
(TB). This illness is a global affliction, and the WHO estimates that it affects 2 billion people, 
which means that a third of the world’s population is infected with the bacillus Mycobacterium 
tuberculosis (M.tb) (see figure 2). The bacillus is capable of lying dormant in a human body for 
years until an individual’s immunity system becomes unable to ward off the infection and incapable 
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of destroying the bacillus. While the majority of people with the latent infection never develop the 
active form of the disease, between 5% and 10% of the carriers will be afflicted by it during their 
lives. Over 95% of TB deaths occur in low- and middle-income countries, and it is among the top 
three causes of death for women aged 15 to 44. In 2011 alone it is estimated that globally over 1.4 
million people died as a direct result of tuberculosis while another 8.7 million developed the active 
form of the disease (“WHO | Tuberculosis”, 2012). Although in some parts of the world incidence 
rates are falling, in those where poverty is prevalent and HIV/AIDS rates are high the disease has 
maintained a continuous growth rate, and it is the principal infectious disease responsible for 
AIDS/HIV mortalities. This global pandemic disease is deepening the chasm which separates rich 
and poor countries and further accentuating global social stress. For example, in 2009 alone, almost 
10 million children were orphaned by parental mortalities caused by tuberculosis (Vasconcellos & 
Morel, 2012). 
 
Figure 2 - Global Tuberculosis – Report 2012 (WHO, 2012). 
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Accordingly, use the Web 2.0 tools for help innovation management in health global, mainly 
ND seems a good way for no-developed countries and other threatened by such disease. 
 
 
2 METHODS 
 
This work is descriptive, accomplished through databases available on the web. So, 
numerous tools to improve web information organization has been appearing since O’Reilly (2007) 
attempts to define and understand the Web 2.0 (O’Reilly, 2007). Thus, there is a massive amount of 
information in different formats, being necessary subsequent treatments of these data in order to 
produce indicators for decision making. Hence, the method for obtaining and utilizing the 
information passes through the Application Programming Interface (API) allowing working data in 
computer programs, having effectively robust downloading of information using all the possibilities 
via API in turn explore the potential of Web. Thereby, there is no presumption of bringing new 
indicator, but demonstrate the use for non-experts. 
In this sense, first was held bibliographical survey and theoretical basis through the indexed 
databases such as PubMed, Science Direct and Web of Knowledge of the Institute for Scientific 
Information (ISI). Subsequently, researched term "tuberculosis" into PubMed, World Intellectual 
Property Organization (WIPO) and HealthMap – the data were processed at the own base and later 
analyzed, as well as patents analysis. 
 
 
3 DISCUSSION 
 
Need better management of information from the "Knowledge Age" and the technology 
involved. Should be considered adaptation to actual conditions of each local culture and 
collaboration of R,D&I through collaborative networks for dissemination of knowledge beyond 
development and innovation. Work with Information Science for whatever application area 
comprises a highly structured network (Le Moigne, 1994; Quoniam & Lucien, 2010). Since the 
processes involved in R,D&I drugs are increasingly complex, there is a need to train 
multidisciplinary teams in order to establish a systemic view (Ferreira et al., 2013). 
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Solomon et al. (2012) conceptualize four time points or periods at which disease elimination 
programmers require diagnostics: 1) Mapping to establish baseline disease prevalence, facilitating 
targeting of interventions. 2) Impact monitoring after interventions have commenced. 3) The 
stopping decision, which determines whether the pre-defined elimination target has been reached, 
allowing discontinuation of interventions. 4) Post-elimination surveillance after intervention has 
ceased (Solomon et al., 2012). Therefore, Web 2.0 tools can aid in the management of these four 
periods. 
Moreover, several procedures have been suggested to cope with the three types of “health 
failures”: (a) Science failures (insufficient knowledge prevents the development of health products 
such as malaria and HIV vaccines): Stimulate basic, fundamental research and technological 
development, (b) Market failures (high prices prevent access of drugs by needy populations): Price 
reduction policies (resulting e.g. from negotiations between governments and industry) or creating 
subsidizing mechanisms leading to lower prices, and (c) Health service failures (inexpensive drugs 
do not reach the patients): Fighting corruption, reducing inequalities and coping with cultural, 
religious or infrastructure barriers, etc. that prevent access to cheap or free drugs by poor countries 
(Morel, Serruya, Penna, & Guimarães, 2009). 
Therefore, improving the health of the poorest people in the developing world depends on 
the development and deployment of many varieties of health innovations, including new drugs, 
vaccines, devices, and diagnostics, as well as new techniques in process engineering and 
manufacturing, management approaches, software, and policies in health systems and services 
(Morel et al., 2005). 
Mapping and location of these partnerships encourage better planning of R,D&I for 
businesses and institutions. Become possible to analyze each and expert information about their 
work and performance when identifying the current landscape and precede the future. Info planned 
and organized provides subsidies managers to better define public policies and stimulate research. 
Likewise, in management of DN field whether in prevention, control, treatments and new 
technologies (Magalhães, Boechat, & Antunes, 2012b). 
Morel et al. (2009) shows that co-authorship network analysis could become an important 
tool for international organizations or partnerships targeting the elimination or eradication of 
diseases, providing science-based information relevant to strategic analysis and planning. Lessons 
from past eradication campaigns demonstrated the importance of maximizing the utilization of 
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scarce human and financial resources, functioning within existing health service structures and 
encouraging research at all levels (Morel et al., 2009). 
In the biomedical literature base of over millions of PubMed abstracts since 1953, can 
perform a bibliometric analysis to show a lot of information’s for management, such as: the growth 
in TB publications over time and respective authors, relations and co-relations on theme, intensity 
of researchers’ countries, trends etc. Figure 3 shows the evolution of scientific publications on TB 
in about 40 years. Noteworthy is the Relative Research Interestii in the early 70s and gradually 
falling to the 90s and remain almost stable until the year 2012. Index for Relative Research Interest 
(smoothed)iii come in search of a way. 
 
Figure 3 – Scientific papers in PubMed database (“Home - PubMed - NCBI”, 2013). 
 
 
Figure 4 shows location of the research institutes that are working with TB. Note the 
intensity of research on the topic in the countries with the highest amount of points on the map. 
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Figure 4 - Map of the institutions' experts localization (“Home - PubMed - NCBI”, 2013). 
 
191,981 scientific papers have been published related to TB. The five largest producers are 
the USA with 7.4%, India (3.5%), UK (2.5%), Japan (2.2%) and China (1.6%). Brazil appears 11th 
in the ranking with 0.9% of the total – 1,680 papers (see figure 5). Although the USA is leading in 
the polls when looking for cities, London is the main with 2.379 papers publications. 
 
Figure 5 - Number of publications in TB over the years by countries and cities (“Home - PubMed - NCBI”, 
2013). 
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Trends evaluation through patents evolution is a strong indicator of R,D&I (Antunes & 
Magalhães, 2008). So, when an analyzed patent in the OMPI database shows 2693 patents existing 
for TB in the past 10 years, in the PCTiv deposit are 29.6% (797 patents) and 552 in the basis of the 
European Community (European Patent Office – EPO), Brazil has 1.7% of total patents. Excluding 
deposits PCT and EPO, the TOP 10 nations with highest patents number are Russian Federation 
with 649, Republic of Korea (143), Spain (120), Japan (113), Mexico (90), South Africa (50), 
Brazil (45), Argentina (32), Israel (30), Singapore (13) and Colombia (9). Figure 6 shows the 
distribution by countries and groups PCT and EPO. 
 
Figure 6 - Patents distributions’ in OMPI databases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 shows major companies holding patents on TB where Corixa Corporation is the 
principal and Sankt-Peterburgsk less deposits. Beside can see deposits evolution over the years. 
Even showing an increase between the years 2008 and 2012 can be gauged constancy towards 
technologies in TB. 
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Figure 7 - Holding patents and deposit evolution. 
 
Efforts have been made by institutions around the world for solving global health problems, 
however need for management of technological innovation has been a challenge. Therefore, models 
to facilitate the management process have been employed using various tools in order to integrate 
expert networks for common goal. One example of success is the Global Alliance for TB Drug 
Development (TB Alliance) – a not-for-profit, product development partnership accelerating the 
discovery and development of new TB drugs that will shorten treatment, be effective against 
susceptible and resistant strains, be compatible with antiretroviral therapies for those HIV-TB 
patients currently on such therapies, and improve treatment of latent infection. It works with public 
and private partners worldwide. 
 
 
4 CONCLUSIONS 
 
 Some bases provide open access democratization of indicators that can be used for the 
problems of diseases that do not interest the pharmaceutical labs. 
 Use of Web 2.0 to analyze the technological forecasting research in TB was effective, given 
the growing publication in the area in question, by number of patents observed with 
protection in PTC countries as well as developing nations. 
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 Mapping of the location of the partnerships promote a better planning of R,D&I and  
knowledge uptake by businesses and institutions. Thus, it is possible to analyze each and 
expert information about their work and performance. 
 Pioneer country in research by specialists is the same what else inserts patents in the area 
(USA) followed by the BRIC countries (Brazil, Russia, India and China). 
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i Web term (World Wide Web) – Web 2.0 considers the communication that occurs in a collaborative and dynamic, i.e., 
several to several people and taking the Web such as a platform (O’Reilly, 2007). 
ii Relative Research Interest is computed as the fraction of the number of articles of that topic (search query) from the 
specific year over the total number of articles of that year, such as R(y) = n(y, q) / N(y), where n(y,q) = number of 
articles for query q in year and y N(y) = number of articles in year y. 
iii Relative Research Interest (smoothed) is the relative research interest smoothed by a sliding window of 5 years: S(y) 
= mean (R(y-4), R(y-3), R(y-2), R(y-1), R(y)) (not available values are ignored). 
iv Patent Cooperation Treaty: allows the company to make a single depositor patent application and in a single language. 
This applies to the signatories countries of this treaty. From this single deposit the depositor has up to 12 months to 
choose the countries where the patent it'll be deposit. 
